Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$123.8 - $132.96 $204,270 - $219,384
1,650 New
1,650 $204,000
Q3 2023

Oct 05, 2023

BUY
$102.95 - $114.33 $10,295 - $11,433
100 Added 1.32%
7,669 $789,000
Q2 2023

Jul 11, 2023

BUY
$108.61 - $118.38 $25,306 - $27,582
233 Added 3.18%
7,569 $873,000
Q4 2022

Feb 15, 2023

SELL
$87.44 - $112.11 $54,125 - $69,396
-619 Reduced 7.78%
7,336 $813,000
Q3 2022

Nov 03, 2022

BUY
$84.53 - $94.96 $21,808 - $24,499
258 Added 3.35%
7,955 $685,000
Q2 2022

Jul 15, 2022

BUY
$83.49 - $94.64 $189,856 - $215,211
2,274 Added 41.93%
7,697 $702,000
Q1 2022

May 06, 2022

SELL
$73.51 - $82.4 $82,037 - $91,958
-1,116 Reduced 17.07%
5,423 $445,000
Q4 2021

Jan 31, 2022

BUY
$72.28 - $90.54 $115,648 - $144,864
1,600 Added 32.4%
6,539 $501,000
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $58,705 - $64,561
819 Added 19.88%
4,939 $371,000
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $843 - $933
12 Added 0.29%
4,120 $320,000
Q1 2021

Apr 28, 2021

SELL
$68.86 - $81.11 $72,991 - $85,976
-1,060 Reduced 20.51%
4,108 $317,000
Q4 2020

Feb 08, 2021

BUY
$71.77 - $79.65 $370,907 - $411,631
5,168 New
5,168 $423,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Life Pro Asset Management Portfolio

Follow Life Pro Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Life Pro Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Life Pro Asset Management with notifications on news.